| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 05/27/2009 | EP2062884A1 Novel phenylacetic acid derivative |
| 05/27/2009 | EP2061760A1 Benzo-fused compounds for use in treating metabolic disorders |
| 05/27/2009 | EP2061755A1 Tricyclic compounds useful in treating iron disorders |
| 05/27/2009 | EP2061754A1 Biaryl and biheteroaryl compounds useful in treating iron disorders |
| 05/27/2009 | EP2061449A1 Substituted acetylenic compounds useful for the treatment of diseases |
| 05/27/2009 | EP1694627B1 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics |
| 05/27/2009 | EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators |
| 05/27/2009 | CN101440083A Method for extracting thiophen from coking crude benzol |
| 05/27/2009 | CN100491387C Ferrocenyl imidazoliny palladium compound, its preparation method and its uses in catalytic synthesis of coupling product |
| 05/27/2009 | CN100491382C Preparation process of clopidogre and its salt |
| 05/27/2009 | CN100491370C Sulfamate benzothiophene ester derivatives as steroid sulfatase inhibitors |
| 05/27/2009 | CN100491369C Method for producing enantiomer-pure aminoalcohols |
| 05/27/2009 | CN100491356C Compounds exhibiting thrombopoietin receptor agaonism |
| 05/27/2009 | CN100491355C Cyclic diamine compound having five-membered cyclic group |
| 05/27/2009 | CN100491323C Biaryloxymethylarenecarboxylic acids compound |
| 05/27/2009 | CN100491316C Novel compounds, their preparation and use |
| 05/27/2009 | CN100490970C Expanded graphite supporting NiB amorphous alloy catalyst, its preparation method and application |
| 05/26/2009 | US7538232 Reacting 3-methylamino-1-(2-thienyl)-1-propanol with potassium hydroxide and 1-fluoronaphthalene in DMSO and toluene mixed solvent; racemization prevention; purity, yield |
| 05/26/2009 | US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/26/2009 | US7538138 Histamine-3 receptor antagonists; 4-(2-{2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl}-1-benzofuran-4-yl)benzonitrile; acute myocardial infarction, asthma, psychological disorders, gastrointestinal disorders, inflammation, jet lag, cancer, septic shock, Tourette's syndrome, neurodegenerative disorders |
| 05/26/2009 | CA2459432C Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 05/26/2009 | CA2344058C Diaminopropionic acid derivatives |
| 05/26/2009 | CA2337041C Aminomethylcarboxylic acid derivatives |
| 05/26/2009 | CA2225903C Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use |
| 05/22/2009 | WO2009064251A1 Bis-(sulfonylamino) derivatives in therapy 066 |
| 05/22/2009 | WO2009064250A1 Bis-(sulfonylamino) derivatives in therapy 065 |
| 05/22/2009 | WO2009063171A1 Novel rotigotine salts |
| 05/22/2009 | WO2009063170A1 Preparation of crystalline rotigotine base |
| 05/22/2009 | WO2009062659A2 Polymorphs of enantiopure erdosteine |
| 05/22/2009 | WO2008043567A8 2-phenyl indene derivatives useful as estrogen receptor ligands |
| 05/22/2009 | CA2705755A1 Bis-(sulfonylamino) derivatives in therapy 066 |
| 05/21/2009 | US20090131684 Photoacid generator, chemically amplified resist composition including the same, and associated methods |
| 05/21/2009 | US20090131510 Compounds with activity at estrogen receptors |
| 05/21/2009 | US20090131509 Aminoacid Derivatives Containing a Disulfanyl Group in the form of Mixed Disulfanyl and Aminopeptidase N Inhibitors |
| 05/21/2009 | US20090131468 Bis-(Sulfonylamino) Derivatives in Therapy 065 |
| 05/21/2009 | US20090131411 monoamidino-containing compounds having good bioavailability and/or solubility, used as potent and specific inhibitors of blood coagulation in mammals, and as therapeutic agents for disease states characterized by coagulation disorders |
| 05/21/2009 | US20090131400 Immunosuppressant compounds and compositions |
| 05/21/2009 | US20090131256 Substituted 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane Compounds |
| 05/21/2009 | US20090127491 Thiophene compound having sulfonyl group and process for producing the same |
| 05/20/2009 | EP2060600A1 Resist composition, method of forming resist pattern, novel compound, and acid generator |
| 05/20/2009 | EP2060568A1 Polymorphs of enantiopure erdosteine |
| 05/20/2009 | EP2060559A1 Process for the preparation of enantiomerically pure 3-hydroxy-3-arylpropylamines and their optical stereoisomers |
| 05/20/2009 | EP2059507A2 Ep2 agonists |
| 05/20/2009 | EP2003116A9 Process for the production of organic oxides |
| 05/20/2009 | EP1888058B1 Inhibitors of soluble adenylate cyclase |
| 05/20/2009 | CN101437809A Glycosidase inhibitors and methods of synthesizing same |
| 05/20/2009 | CN101434517A Novel 1,2-diphenylethene derivatives for treatment of immune diseases |
| 05/20/2009 | CN100488967C Process for preparing dibenzyl biotin |
| 05/20/2009 | CN100488947C Serine protease inhibitors |
| 05/20/2009 | CN100488923C Double-loop coil organic compounds and electric-field luminescent devices |
| 05/19/2009 | US7534900 Crystallizing duloxetine HCl in water or a solvent selected from C3-8 ketones, C3-8 esters, C2-8 ethers, C2-8 alcohols, and mixtures thereof with water; chemically and/or enantiomerically pure; for the treatment of stress urinary incontinence, depression, and pain management |
| 05/19/2009 | US7534894 2-[(4'-{[5-(2-chlorophenyl)-2-(trifluoromethyl)-3-furoyl]amino}-1,1'-biphenyl-3-yl)oxy]-3-phenylpropanoic acid ; thrombosis, atrial fibrillation, pulmonary fibrosis, stroke, myocardial ischemia, atherosclerotic plaque formation, chronic obstructive pulmonary disease, or renal fibrosis |
| 05/19/2009 | US7534811 Cyclic onium compounds and glucosidase inhibitors |
| 05/19/2009 | US7534791 e.g. [2-(Benzo[b]furan-3-ylsulfanyl)-benzyl]-methyl-amine; serotonin and noradrenaline reuptake inhibitors; antidepressant, anxiolytic agent, pdychological disorders, analgesic, neurodegenerative diseases |
| 05/19/2009 | US7534790 Aminocyclohexyl ether compounds such as trans-[2-(4-morpholinyl)-1-(2-naphthenethoxy)]cyclohexane; arrhythmia, analgesia and local anesthesia |
| 05/19/2009 | US7534475 For preparation of thin phase retarder, such as wide-ranged polarization plate, which gives inverse wavelength distribution |
| 05/19/2009 | CA2209167C Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 05/14/2009 | WO2009061811A1 Substituted cyclopentanes having prostaglanding activity |
| 05/14/2009 | WO2009036000A3 Methods of treating a microbial infection by modulating rnase-l expression and/or activity |
| 05/14/2009 | WO2008137816A3 Tricyclic compounds as matrix metalloproteinase inhibitors |
| 05/14/2009 | US20090124676 Substituted cyclopentanes having prostaglandin activity |
| 05/14/2009 | US20090124669 Structural Analogues of Avenanthramides, Their Use in Compositions Useful in the Treatment of Dermatological Disorders |
| 05/14/2009 | US20090124664 (R)-Arylalkylamino Derivatives and Pharmaceutical Compositions Containing Them |
| 05/14/2009 | US20090124620 Plasminogen activator inhibitor-1 inhibitor |
| 05/14/2009 | US20090123514 Electropolymerizable Monomers and Polymeric Coatings on Implantable Devices Prepared Therefrom |
| 05/14/2009 | CA2705150A1 Substituted cyclopentanes having prostaglandin activity |
| 05/13/2009 | EP2057118A2 Compounds for treatment of proliferative disorders |
| 05/13/2009 | EP2057115A1 4-substituted phenoxyphenylacetic acid derivatives |
| 05/13/2009 | EP1788876B1 Method for manufacturing imidazole compounds and salts and pseudopolymorphs thereof |
| 05/13/2009 | EP1565429B1 Diaryl ureido derivatives and their medical use |
| 05/13/2009 | CN101432272A Aromatic amine derivative, and organic electroluminescence element using the same |
| 05/13/2009 | CN101429189A 2,3-disubstituted aryl thiophene derivants and uses thereof |
| 05/13/2009 | CN100486974C Method of preparing dulouxetine |
| 05/12/2009 | US7531672 Preparation of heterocyclic ketones |
| 05/12/2009 | US7531655 Large conductance calcium-activated K channel opener |
| 05/12/2009 | US7531619 Process for producing dendrimer, building block compound, and process for producing thiophene compound |
| 05/12/2009 | US7531559 Fungicidal 1,2,3 triazole derivatives |
| 05/12/2009 | US7531557 oral bioavailablility, oral administration; inhibition of orexigenic effects; side effects reduction; alcoholism; 6-(2-Fluoro-4-{[2-(tetrahydro-pyran-4-yl)-ethylamino]-methyl}-phenoxy)-nicotinamide |
| 05/12/2009 | US7531538 α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 05/12/2009 | CA2335353C Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ards) and infant respiratory distress syndrome (irds) |
| 05/07/2009 | WO2009057784A1 Heterocyclic compound |
| 05/07/2009 | WO2009056791A1 Processes for preparing pharmaceutical compounds |
| 05/07/2009 | WO2009055917A1 Inhibitors of histone deacetylase |
| 05/07/2009 | WO2009023160A3 Novel inhibitors of bacterial sortase enzymes and methods of using the same |
| 05/07/2009 | WO2006027798A3 A process for preparation of an antidepressant compound |
| 05/07/2009 | US20090118521 Nanoengineered organic nonlinear optical glasses |
| 05/07/2009 | US20090118323 Antitumor benzoylsulfonamides |
| 05/07/2009 | CA2703718A1 Inhibitors of histone deacetylase |
| 05/06/2009 | EP2055701A1 Aromatic amine derivatives and organic electroluminescent devices made by using the same |
| 05/06/2009 | EP2055700A1 Aromatic amine derivatives and organic electroluminescence devices using the same |
| 05/06/2009 | EP2055689A1 Method for producing an optically active nitro compound |
| 05/06/2009 | EP2055378A1 Method for preparing ruthenium-carrying alumina and method for oxidizing alcohol |
| 05/06/2009 | EP2054401A1 Thiophenecarboxamide derivatives as ep4 receptor ligands |
| 05/06/2009 | EP2054388A1 Viral polymerase inhibitors |
| 05/06/2009 | EP1465861B1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 05/06/2009 | CN101426763A Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 05/06/2009 | CN101426495A CB1 antagonists and inverse agonists |
| 05/06/2009 | CN101426486A Compounds for the treatment of inflammatory disorders and microbial diseases |
| 05/06/2009 | CN101423512A Synthetic method of (S)-N,N-dimethyl-3-hydroxyl-3-(2-thiophen)propanamine |
| 05/06/2009 | CN100484936C Synthesis of (2S,6R)-6-amino-2(2-thienyl)1,4-parathiazine-5-ketone |